Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 8/12/2019
SIETES contiene 92850 citas

 
 
 1 a 20 de 119 siguiente >>
Presentar resultados
Seleccionar todas
2. Cita con resumen
Seth P, Scholl L, Rudd RA, Bacon S. Overdose deaths involving opioids, cocaine, and psychostimulants — United States, 2015–2016. Morbidity and Mortality Weekly Report 2018;67:30 de marzo. [Ref.ID 102488]
3.Tiene citas relacionadas Cita con resumen
Socías ME, Wood E. Epidemic of deaths from fentanyl overdose. BMJ 2017;359:j4355. [Ref.ID 102107]
5. Cita con resumen
Imbernón-Moya A, Chico R, Aguilar-Martínez A. Manifestaciones cutáneas y mucosas asociadas al consumo de cocaína. Med Clin (Barc) 2016;146:544-9. [Ref.ID 100354]
6. Cita con resumen
Taylor P, Nutt D, Fortson R, Henderson G, on behalf of DrugScience. Ketamine—the real perspective. Lancet 2016;387:1271-2. [Ref.ID 100277]
7. Cita con resumen
Smyth A, Teo KK, Rangarajan S, O'Donnell M, Zhang X, Rana P, Leong DP, Dagenais G, Seron P, Rosengren A, Schutte AE, Lopez-Jaramillo P, Oguz A, Chifamba J, Díaz R, Lear S, Avezum A, Kumar R, Mohan V, Szuba A, Wei L, Yang W, Jian B, McKee M, Yusuf S, PURE Investigators. Alcohol consumption and cardiovascular disease, cancer, injury, admission to hospital, and mortality: a prospective cohort study. Lancet 2015;386:1945-54. [Ref.ID 99672]
9.
Milloy M-J, Wood E. Withdrawal from methadone in US prisons: cruel and unusual?. Lancet 2015;386:316-8. [Ref.ID 99366]
10.Enlace a cita original Cita con resumen
Kriegbaum M, Hendriksen C, Vass M, Mortensen EL, Osler M. Hypnotics and mortality—partial confounding by disease, substance abuse and socioeconomic factors?. Pharmacoepidemiol Drug Saf 2015;24:779-83. [Ref.ID 99319]
11. Cita con resumen
Anónimo. Study: researchers bio-engineer yeast to turn sugar into precursor for narcotics. DIA Daily 2015:19 de mayo. [Ref.ID 99054]
12. Cita con resumen
Weaver T, Metreblan N, Hellier J, Pillig S, Charles V, Little N, Poovendran D, Mitcheson L, Ryan F, Bowden-Jones O, Dunn J, Glasper A, Finch E, Strang J. Use of contingency management incentives to improve completion of hepatitis B vaccination in people undergoing treatment for heroin dependence: a cluster randomised trial. Lancet 2014;384:153-63. [Ref.ID 97813]
13. Cita con resumen
Anónimo. US college students abusing medication for academic purposes. DIA Daily 2014:5 de mayo. [Ref.ID 97508]
14. Cita con resumen
Grosshans M, Lemenager T, Vollmert C, Kaemmerer N, Schreiner R, Mutschler J, Wagner X, Kiefer F, Hermann D. Pregabalin abuse among opiate addicted patients. Eur J Clin Pharmacol 2013;69:2021-5. [Ref.ID 96638]
15. Cita con resumen
Gunderson EW. Synthetic cannabinoids: a new frontier of designer drugs. Ann Intern Med 2013;159:563-4. [Ref.ID 96386]
16. Cita con resumen
Young K. Unconfirmed reports of krokodil abuse in U.S.. Physician's First Watch 2013:18 de octubre. [Ref.ID 96247]
18. Cita con resumen
Anónimo. Acute kidney injury associated with synthetic cannabinoid use — Multiple states, 2012. Morbidity and Mortality Weekly Report 2013;62:93-8. [Ref.ID 94698]
20. Cita con resumen
Seetohul LN, Maskell PD, De Paoli G, Pounder DJ. Designer drugs. Deaths associated with new designer drug 5-IT. BMJ 2012;345:22. [Ref.ID 93701]
Seleccionar todas
 
 1 a 20 de 119 siguiente >>